Navigation Links
Autism Speaks creates Delivering Scientific Innovation for Autism LLC
Date:10/25/2012

NEW YORK, N.Y. (October 25, 2012) Autism Speaks, the world's leading autism science and advocacy organization, today announced the formation of Delivering Scientific Innovation for Autism (DELSIA) an independent not-for-profit affiliate of Autism Speaks that will work directly with for-profit sector partners to stimulate the conversion of scientific research from the lab into products needed by both the autism and medical communities, more rapidly and effectively.

"There is an urgent need for autism therapies, medications and devices now, and we are committed to leading both the research and the developments that will benefit the thousands of people who struggle with autism every day," stated Autism Speaks Chief Science Officer Geraldine Dawson, Ph.D., who will chair DELSIA's independent board of managers. "Autism Speaks has funded important research that holds great promise for delivering more effective ways to diagnose and treat autism and it's crucial that we apply what we are learning in the lab to real world solutions that can improve the lives of people living with autism today."

DELSIA will help to advance Autism Speaks' mission by accelerating the development of medicines, treatments, diagnostic tools, therapeutic technologies and devices, and other products that originate from breakthroughs in autism research. DELSIA provides a model of venture philanthropy to take ground-breaking research being done in the lab and facilitate development of those products. While Autism Speaks already invests in scientific research that produces papers for publication or for presentation at professional conferences, this next generation philanthropy will produce medical and non-medical treatments, products and devices to be directly used by the community.

"It's necessary to engage partners from the for-profit sector in order to realize the real-world value promised in the scientific breakthroughs we read about in papers every day," explained DELSIA President Robert H. Ring, Ph.D. Dr. Ring also serves as Autism Speaks Vice President for Translational Research. "With the formation of DELSIA, we have created a model for funding to ensure that development activity by DELSIA's commercial partners is squarely aligned to address unmet needs of our community."

DELSIA will utilize scientific, legal, regulatory and business expertise to identify and fund only the most promising development opportunities. As an affiliate of Autism Speaks, DELSIA will operate with separate governance and accounting, but will operate exclusively on funding provided through awards from Autism Speaks and will not be involved in its own fundraising. The DELSIA board of managers, however, will include some individuals familiar with the operations and mission of Autism Speaks, Gary Goldstein and Adrian Jones, who will also remain on the Autism Speaks board of directors.

DELSIA's partnerships with entrepreneurial organizations will include terms for sharing a portion of positive outcomes, such as royalties. The goal of DELSIA is to create better products that will make a difference, not to create profits. Any positive returns will be converted directly into new awards aimed at creating additional products that can be of immediate benefit to people with autism.


'/>"/>
Contact: Jane E. Rubinstein
jrubinstein@rubenstein.com
212-843-8287
Autism Speaks
Source:Eurekalert  

Related medicine news :

1. An Early Start for Your Child with Autism
2. IntegraGen launches ARISk test, a genetic screening tool for autism in high-risk children
3. Researchers Find Gene Mutations That May Be a Key to Autism
4. Pregnancy Length May Influence Severity of Autism
5. Children Born to Obese Moms May Face Higher Autism Risk: Study
6. Online Tool Could Diagnose Autism Quickly, Developers Say
7. Autism by the numbers: Yale researchers examine impact of new diagnostic criteria
8. In Mice, Drug Reverses Symptoms of Condition Linked to Autism
9. Study of half siblings provides genetic clues to autism
10. Genes Associated With Autism Also Related to Schizophrenia
11. Publication Bias Casts Doubt on Value of Antidepressants for Autism
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Autism Speaks creates Delivering Scientific Innovation for Autism LLC
(Date:5/27/2016)... ... May 27, 2016 , ... With a ... medical and food industries. Aside from its GMP accreditation, Validation Center is also ... successfully certified products, services and staff. , Validation Center is ISO17025 accredited and ...
(Date:5/26/2016)... ... ... There are many ways to cook a hot dog, but new research ... their dogs straight off the grill. Of the 90 percent of Americans who say ... a hot dog, far outpacing other cooking methods such as steaming (12 percent), microwaving ...
(Date:5/26/2016)... California (PRWEB) , ... May 26, 2016 , ... ... associated with discovery of thousands of defective respirators, according to court documents and ... the case of William and Becky Tyler v. American Optical Corporation, Case No. ...
(Date:5/26/2016)... ... May 26, 2016 , ... Georgia State University College of ... programs. , Answering to the increasing demand for curricular specializations, the Certificate in ... environmental and land use law. ,  , “The demand for lawyers with specific ...
(Date:5/26/2016)... ... ... On Memorial Day, Hope For Heroes and USA Medical Card ... the country. The nonprofit Hope For Heroes partnered with the leading provider of ... disabled military veterans, as well as police, firemen, and EMS professionals across the country, ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... Inivata, a global clinical ... tumour DNA (ctDNA) analysis to improve personalised healthcare ... Clive Morris as Chief Medical Officer. ... development programme, scientific collaborations, and through to commercialisation ... in clinical outcomes for patients. Clive ...
(Date:5/24/2016)... --   , Study met ... cleansing and superiority in , Excellent ... of the ascending colon   , ... Norgine B.V. today announced new positive data from the phase III ... versus standard 2 litre PEG with ascorbate. The study met both ...
(Date:5/24/2016)... , May 24, 2016  Joe Marziani has joined VMS BioMarketing as senior ... executive officer, today. In his new role, Marziani will lead the company,s business development ... professionals to improve outcomes. Photo - http://photos.prnewswire.com/prnh/20160523/371089 ... ... ...
Breaking Medicine Technology: